Hyperpolarized C13 pyruvate
- Generic Name
- Hyperpolarized C13 pyruvate
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma
Phase 1
Recruiting
- Conditions
- Primary CNS Lymphoma
- Interventions
- Procedure: Magnetic resonance imaging (MRI)
- First Posted Date
- 2020-12-07
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- James Rubenstein
- Target Recruit Count
- 25
- Registration Number
- NCT04656431
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Imaging of Traumatic Brain Injury Metabolism Using Hyperpolarized Carbon-13 Pyruvate
Early Phase 1
- Conditions
- Traumatic Brain Injury
- Interventions
- Drug: Hyperpolarized [2-13C] Pyruvate
- First Posted Date
- 2018-04-19
- Last Posted Date
- 2023-09-15
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT03502967
- Locations
- 🇺🇸
UT Southwestern - Advanced Imaging Research Center, Dallas, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath